Mesa Laboratories, Inc. Forecast, price target & analysts
Mesa Laboratories, Inc. Target price 2026 - Analyst rating & recommendation
Mesa Laboratories, Inc. Classifications & Recommendation
Mesa Laboratories, Inc. Price Target
| Target Price | $119.85 |
| Price | $132.55 |
| Deviation |
9.58%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Mesa Laboratories, Inc. 2027 .
The average Mesa Laboratories, Inc. target price is $119.85.
This is
9.58%
register free of charge
$131.25
0.98%
register free of charge
$111.10
16.18%
register free of charge
|
|
| A rating was issued by 9 analysts: 6 Analysts recommend Mesa Laboratories, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Mesa Laboratories, Inc. stock has an average upside potential 2027 of
9.58%
register free of charge
|
Sales and Margin forecast 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million $ | 249.13 | 260.39 |
| 3.38% | 4.52% | |
| EBITDA Margin | 16.23% | 24.36% |
| 14.79% | 50.11% | |
| Net Margin | 2.69% | 4.84% |
| 429.47% | 79.70% |
5 Analysts have issued a sales forecast Mesa Laboratories, Inc. 2027 . The average Mesa Laboratories, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Mesa Laboratories, Inc. EBITDA forecast 2027. The average Mesa Laboratories, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Mesa Laboratories, Inc. Analysts have issued a net profit forecast 2027. The average Mesa Laboratories, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.21 | 2.25 |
| 436.11% | 85.95% | |
| P/E | 58.89 | |
| EV/Sales | 3.28 |
5 Analysts have issued a Mesa Laboratories, Inc. forecast for earnings per share. The average Mesa Laboratories, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Mesa Laboratories, Inc....
Current Mesa Laboratories, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 14 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 04 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Dec 15 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 30 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Oct 01 2024 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 27 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 14 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 04 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Dec 15 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 30 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Oct 01 2024 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 27 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
